VitaNova Life Sciences Corp (VNOV) stock
VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30
$4.50+0.50 (+12.50%)
Close on Oct 19, 2026Market cap $37.52MP/E –Yield –
VitaNova Life Sciences operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
VitaNova Life Sciences's operating income for the twelve months ending Jul 31, 2026 was -$86.12K, down 107.1% year over year. For fiscal 2026 it was $3.60K, down 99.7% from the year before. The highest annual figure on record is $1.21M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | $3.60K | -99.7% |
| FY2025 | Apr 30, 2025 | $1.21M | +487.6% |
| FY2024 | Apr 30, 2024 | $205.63K | – |
| FY2023 | Apr 30, 2023 | -$24.23K | – |
| FY2022 | Apr 30, 2022 | -$13.37K | – |
| FY2021 | Apr 30, 2021 | -$52.09K | – |
| FY2020 | Apr 30, 2020 | -$72.33K | – |
| FY2019 | Apr 30, 2019 | -$71.81K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | -$122.16K | – |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | -$109.86K | -110.2% |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | $46.73K | -57.1% |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | $99.17K | +58.4% |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | -$32.44K | – |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | $1.08M | +365.1% |
| Q3 FY2025CQ4 2024 | Jan 31, 2025 | $108.87K | +1730.4% |
| Q2 FY2025CQ3 2024 | Oct 31, 2024 | $62.60K | – |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | -$45.41K | – |
| Q4 FY2024CQ1 2024 | Apr 30, 2024 | $232.68K | +10803.6% |
| Q3 FY2024CQ4 2023 | Jan 31, 2024 | $5.95K | – |
| Q2 FY2024CQ3 2023 | Oct 31, 2023 | -$8.76K | – |
| Q1 FY2024CQ2 2023 | Jul 31, 2023 | -$24.25K | – |
| Q1 FY2023CQ2 2022 | Jul 31, 2022 | $2.13K | – |
| Q2 FY2022CQ3 2021 | Oct 31, 2021 | -$29.99K | – |
| Q1 FY2022CQ2 2021 | Jul 31, 2021 | -$10.49K | – |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | -$25.56K | – |
| Q3 FY2021CQ4 2020 | Jan 31, 2021 | -$2.90K | – |
| Q2 FY2021CQ3 2020 | Oct 31, 2020 | -$12.39K | – |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | -$11.25K | – |
| Q4 FY2020CQ1 2020 | Apr 30, 2020 | -$26.34K | – |
| Q3 FY2020CQ4 2019 | Jan 31, 2020 | -$6.59K | – |
| Q2 FY2020CQ3 2019 | Oct 31, 2019 | -$19.52K | – |
| Q1 FY2020CQ2 2019 | Jul 31, 2019 | -$19.88K | – |
| Q4 FY2019CQ1 2019 | Apr 30, 2019 | -$13.60K | – |
| Q1 FY2019CQ2 2018 | Jul 31, 2018 | -$15.83K | – |
See a number that looks wrong?